Survival of human prostate carcinoma, benign hyperplastic prostate tissues, and IL-2-activated lymphocytes in SCID mice-Reference-Cited by-同舟云学术

Survival of human prostate carcinoma, benign hyperplastic prostate tissues, and IL-2-activated lymphocytes in SCID mice

Published:1995-07 Issue:1 Volume:27 Page:32-41
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Lubaroff David M.,Cohen Michael B.,Shultz Leonard D.,Beamer Wesley G.

Publisher

Wiley

Subject

Urology,Oncology

Reference25 articles.

1. Cancer statistics, 1994

2. Trends in prostate cancer care in the United States, 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer

3. Endocrine Therapy for Prostate Cancer

4. Synthetic progestins stimulate prostatic binding protein messenger RNAs in the rat ventral prostate

5. , : Complete androgen blockade for the treatment of prostate cancer. In , (eds): Important Advances in Oncology. Philadelphia: JB Lippincott, 1985, pp 193–217.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A TRAMP-derived orthotopic prostate syngeneic (TOPS) cancer model for investigating anti-tumor treatments;The Prostate;2018-02-16

2. Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX;BioMed Research International;2016

3. Murine Models of Prostate Cancer;Prostate Cancer: A Comprehensive Perspective;2012-12-10

4. Human prostate cancer heterotransplants: a review on this experimental model;Asian Journal of Andrology;2010-04-05

5. Human benign prostatic hyperplasia heterotransplants as an experimental model;Asian Journal of Andrology;2009-11-30